Continuous glucose monitoring: review of promising technologies

Klimek, Monika; Tulwin, Tytus

doi:10.1051/matecconf/201925202012

Cited by 1 publication

(3 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Poland, there are a few real-time CGM systems available, e.g., Guardian™ Connect (Medtronic), Dexcom G4, Dexcom G5 and the Eversense CGM. Patients who choose to use CGM have several options available to them, standalone devices or insulin pumps integrated with CGM (MiniMed ® Real Time™ 722, MiniMed ® Veo™, MiniMed ® 640G™ Medtronic) [12].…”

Section: Comparison Of Cgm Systemsmentioning

confidence: 99%

“…The Medtronic and Dexcom systems utilize transcutaneous sensors (transcutaneous real-time CGM -TC rtCGM). They consist of three components: a disposable sensor that is inserted into the subcutaneous tissue to measure glucose levels, a transmitter that attaches to the sensor, and a receiver (stand-alone device, insulin pump, smartphone, smartwatch) that displays and stores glucose information [12].…”

Section: Comparison Of Cgm Systemsmentioning

confidence: 99%

“…The system consists of an implantable, fluorescence-based, cylindrical glucose sensor, a removable external smart transmitter and a mobile medical application that displays glucose information and operates on a mobile device that allows users to review current and historical glucose data in real-time. The Eversense system is indicated for up to 180-days wear time in adults only [12].…”

Section: Comparison Of Cgm Systemsmentioning

confidence: 99%

See 2 more Smart Citations

Experts opinion: implantable continuous glucose monitoring system — innovation in the management of diabetes

Szadkowska

Zozulińska‐Ziółkiewicz

Walczak

et al. 2020

Clinical Diabetology

View full text Add to dashboard Cite

Continuous glucose monitoring (CGM) systems have revolutionized the treatment and monitoring of diabetes. These devices are recommended for diabetic patients treated with insulin, especially with recurring episodes of hypoglycemia or large circadian variation of glucose levels. CGM allows more effective adjustment of insulin doses to blood glucose trends, resulting in better metabolic control: more time spend in glucose target range, lower time spend in hypoglycemic range, lower glucose variability and improved quality of life of patients and their family members. Real time CGM provides patients not only with continuous information on glucose levels but also alerts for hypo-or hyperglycemic events. Traditional transcutaneous CGM have some limitations, which can be resolved by the system with an implantable sensor. The Eversense CGM is the only long-term implantable rtCGM. The subcutaneous implantation procedure has proved to be simple and uncomplicated. This CGM system can be recommended in particular for patients who, due to their profession and sports discipline, cannot or do not want to use traditional transcutaneous sensors. Further groups are patients with skin complications associated with the use of traditional sensors, people who perceive frequent sensor replacement as a burden or would benefit from on-body vibration alerts. The studies showed that the patients were satisfied with Eversense, and the majority used it several times after the study ended. The main reason for resigning from the next implantation was

show abstract

Section: Comparison Of Cgm Systemsmentioning

confidence: 99%

Section: Comparison Of Cgm Systemsmentioning

confidence: 99%

Section: Comparison Of Cgm Systemsmentioning

confidence: 99%

See 1 more Smart Citation